Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SIRT”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00994370
What this trial is testing

Measurement of Pro-angiogenic Markers in Patients With Hepatic Metastases Undergoing SIRT

Who this might be right for
Liver Cancer
Rutgers, The State University of New Jersey 36
Not applicableStudy completedNCT04332419
What this trial is testing

Comparison of Yttrium-90 Absorbed Doses Using PET/CT Versus PET/MR Imaging for Hepatic Malignancies

Who this might be right for
Hepatic Malignancies
Case Comprehensive Cancer Center 11
Early research (Phase 1)Study completedNCT00972036
What this trial is testing

Selective Internal Radiation Therapy (SIRT) in Patients With Unresectable Colorectal Cancer Liver Metastases Who Failed Prior Intraarterial Pump Chemotherapy

Who this might be right for
Colon CancerRectal Cancer
Memorial Sloan Kettering Cancer Center 32
Not applicableUnknownNCT06142344
What this trial is testing

Radioembolisation and Chemotherapy in Liver Metastatic Breast Cancer Patients

Who this might be right for
Liver MetastasesBreast Cancer
The Netherlands Cancer Institute 13
Large-scale testing (Phase 3)Ended earlyNCT02807181
What this trial is testing

SIRT Followed by CIS-GEM Chemotherapy Versus CIS-GEM Chemotherapy Alone as 1st Line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma
Sirtex Medical 89
Not applicableUnknownNCT04833517
What this trial is testing

Prospective REgistry of Targeted RadionucLide TherapY in Patients With mCRPC (REALITY Study)

Who this might be right for
Prostate Cancer MetastaticCastration Resistant Prostatic CancerAdvanced Prostate Carcinoma
Universität des Saarlandes 500
Not applicableStudy completedNCT04069468
What this trial is testing

Non-Interventional Registry Study to Evaluate the Effectiveness of TheraSphere® in the Treatment of Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Boston Scientific Corporation 1,247
Testing effectiveness (Phase 2)Study completedNCT02936388
What this trial is testing

Transarterial Radioembolisation in Comparison to Transarterial Chemoembolisation in Uveal Melanoma Liver Metastasis

Who this might be right for
Uveal Melanoma
Charite University, Berlin, Germany 108
Not applicableStudy completedNCT02305459
What this trial is testing

CIRSE Registry for SIR-Spheres Therapy

Who this might be right for
Liver Carcinoma
Cardiovascular and Interventional Radiological Society of Europe 1,051
Testing effectiveness (Phase 2)Looking for participantsNCT05377034
What this trial is testing

Multinational Phase II Trial to Compare Safety and Efficacy of SIRT (Y-90 Resin Microspheres) Followed by Atezolizumab Plus Bevacizumab, vs SIRT (SIRT-Y90) Followed by Placebo in Locally Advanced HCC Patients

Who this might be right for
Locally Advanced Hepatocellular Carcinoma
National Cancer Centre, Singapore 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT04238637
What this trial is testing

Immunotherapy Combined With Y-90 SIRT Therapy in Advanced Stage Intrahepatic Biliary Tract Cancer (BTC)

Who this might be right for
Intrahepatic Cholangiocarcinoma
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 50
Not applicableLooking for participantsNCT06232889
What this trial is testing

Deuterium Metabolic MRI and [18F]FDG PET for Assessment of Treatment Response Following Radioembolization

Who this might be right for
Fluorodeoxyglucose F18Phosphoric Monoester HydrolasesPhosphoric Diester Hydrolases
UMC Utrecht 15
Testing effectiveness (Phase 2)Ended earlyNCT05797870
What this trial is testing

Selective Internal Radiation Therapy and 188Re-SSS Lipiodol Treatment for Liver Cancer (Lip-Re2)

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Center Eugene Marquis 16
Not applicableLooking for participantsNCT06337227
What this trial is testing

Potential Role of Sirtuins As Epigenetic Biomarkers of the Patient with Atherosclerosis or Calcific Aortic Stenosis

Who this might be right for
Atherosclerosis and Calcific Aortic Stenosis with and Without Diabetes
IRCCS SYNLAB SDN 3
Not applicableNot Yet RecruitingNCT06971237
What this trial is testing

SIRT and Peri-immunotherapy : a New Concept

Who this might be right for
Advanced Hepatocellular Carcinoma (HCC), Classified as BCLC Stage B or C, Treated With a Combination of Selective Internal Radiation Therapy
Assistance Publique - Hôpitaux de Paris 60
Testing effectiveness (Phase 2)Looking for participantsNCT06904196
What this trial is testing

Lenvatinib Plus SIRT vs Lenvatinib in TACE-Refractory HCC

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 78
Testing effectiveness (Phase 2)Looking for participantsNCT05265208
What this trial is testing

Selective Internal Radiation Therapy and Capecitabine (Chemotherapy) Treatment for Liver Cancer

Who this might be right for
Resectable Intrahepatic Cholangiocarcinoma
Center Eugene Marquis 62
Not applicableUnknownNCT03912844
What this trial is testing

European SIR-Spheres Surgical Registry

Who this might be right for
Hepatectomy
Universitätsklinikum Köln 250
Not applicableUnknownNCT04303208
What this trial is testing

Sirtuin 3 and Sirtuin 7 in Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Assiut University 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07663487
What this trial is testing

A Study Evaluating the Safety and Efficacy of Selective Internal Radiation Therapy (SIRT) Using SIR-Spheres® Y-90 Resin Microspheres to Bridge or Downstage Patients With Hepatocellular Carcinoma (HCC) to Liver Transplant or Resection and Elicit Pathologic Necrosis.

Who this might be right for
Hepatocellular Carcinoma (HCC)
Sirtex Medical 78
Next Page